You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pan-RAF inhibitor

Showing 1 - 25 of 8,077
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Advanced Solid Tumors Harboring MAPK Pathway Alterations Trial in Shandong (QLH11906)

Recruiting
  • Advanced Solid Tumors Harboring MAPK Pathway Alterations
  • Shandong, China
    Shandong Cancer Hospital
Aug 3, 2022

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial (Biopsy, Biospecimen Collection,

Not yet recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biopsy
  • +3 more
  • (no location specified)
Dec 22, 2022

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen

Recruiting
  • Recurrent Langerhans Cell Histiocytosis
  • Refractory Langerhans Cell Histiocytosis
  • Biospecimen Collection
  • +8 more
  • Wilmington, Delaware
  • +3 more
Apr 28, 2023

Advanced Solid Tumors Trial in Cincinnati, Houston, Salt Lake City (YL-17231)

Not yet recruiting
  • Advanced Solid Tumors
  • Cincinnati, Ohio
  • +2 more
Oct 22, 2023

PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

Not yet recruiting
  • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
  • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
  • (no location specified)
Sep 24, 2023

Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

Recruiting
  • Cancer
  • +6 more
  • Indianapolis, Indiana
    Indiana University Hospital / IU Simon Cancer Center
Jan 12, 2023

Advanced Solid Tumor Trial in Guangzhou (YL-17231)

Recruiting
  • Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 5, 2023

Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

Active, not recruiting
  • Neoplasm
  • Beijing, China
  • +5 more
Jan 31, 2023

Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Avutometinib, Biospecimen Collection, Defactinib)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 22, 2023

Pediatric Cancer, CNS Tumor, Childhood, Skin Inflammation Trial in Boston (other, drug, behavioral)

Recruiting
  • Pediatric Cancer
  • +2 more
  • Warm Baths or Showers
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jan 31, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

Recruiting
  • NSCLC
  • +3 more
  • Manchester, Greater Manchester, United Kingdom
  • +4 more
Mar 18, 2022

Solid Tumor, B-Raf Mutation-Related Tumors Trial in Australia, United States (BGB-3245)

Recruiting
  • Solid Tumor
  • B-Raf Mutation-Related Tumors
  • Boston, Massachusetts
  • +4 more
Oct 25, 2022

Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)

Active, not recruiting
  • Uveitis
  • Los Angeles, California
  • +3 more
Jul 18, 2022

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Esophageal Cancer Trial in Hat yai (BKM120)

Terminated
  • Esophageal Cancer
  • Hat yai, Songkhla, Thailand
    Songklanagarind Hospital, Prince of Songkla University
Oct 3, 2021

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)

Recruiting
  • Adenoid Cystic Carcinoma
  • Metastatic Adenoid Cystic Carcinoma
  • AL101
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022